Position in BMY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$15,322,737
+$1,291,487 QoQ
Shares Held
252,642
-2.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 26.659066980153735.ToString("F0")%
Shared 0.ToString("F0")%
None 73.34093301984626.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Generali Asset Management SPA SGR holds $342,656,021 across 9 Drug Manufacturers - General names. BMY ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
954,783 | $188,302,303 | |
| 2 | LLY |
ELI LILLY & Co
|
62,651 | $57,624,510 | |
| 3 | MRK |
Merck & Co., Inc.
|
284,084 | $34,172,464 | |
| 4 | AMGN |
Amgen Inc
|
50,205 | $17,664,629 | |
| 5 | ABBV |
AbbVie Inc.
|
80,486 | $17,504,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
252,642 | $15,322,737 | |
| 7 | BIIB |
Biogen Inc.
|
34,194 | $6,268,786 | |
| 8 | PFE |
Pfizer Inc
|
206,394 | $5,795,543 |
All Filings in BMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,322,737 | 252,642 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $14,031,250 | 260,127 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $10,927,143 | 242,287 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $13,431,367 | 290,157 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $14,968,775 | 245,430 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,060,834 | 283,961 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||